UnionStrong® Honors | UnionStrong® Named Among China's Top 30 Precision Diagnostics Companies in the 2026 Golden Tripod Awards

UnionStrong® has been named among the Top 30 companies on the 2026 Golden Tripod Awards Annual China Precision Diagnostics List, recognizing its continued innovation and clinical contributions in AI-powered neurovascular diagnosis and treatment.

Jointly organized by CHC Healthcare Consulting, the Medical Devices and Precision Medicine Industry and Investment Alliance, and Shangtu Consulting, the annual awards recognize outstanding companies advancing China's precision diagnostics industry.

The evaluation considers five key dimensions: technological innovation, industry impact, commercial value, social value, and sustainability. UnionStrong®'s inclusion reflects recognition of its original technological developments, clinical implementation capabilities, and contributions to intelligent neurovascular care.

As AI continues to transform precision medicine, UnionStrong® remains focused on integrating advanced technologies into real-world clinical practice. Through sustained research and development and close collaboration with healthcare institutions, the company aims to make intelligent neurovascular solutions more accessible and support improvements in clinical care.

This recognition, also featured by the Beijing Economic-Technological Development Area's Yicheng Times, further highlights UnionStrong®'s ongoing commitment to innovation and the advancement of AI-enabled healthcare.